Related Experiment Videos

Response of Saccharomyces cerevisiae strains to antineoplastic agents

A Delitheos1, I Karavokyros, E Tiligada

  • 1Department of Experimental Pharmacology, Athens University School of Medicine, Greece.

The Journal of Applied Bacteriology
|October 1, 1995
PubMed

Insights

This study investigated antineoplastic agents

Area of Science:

  • * Pharmacology and Microbiology
  • * Anticancer drug research

Background:

  • * Antineoplastic agents are crucial in cancer therapy.
  • * Understanding their effects on non-target organisms like Saccharomyces cerevisiae can offer insights into drug mechanisms and resistance.

Purpose of the Study:

  • * To evaluate the sensitivity of Saccharomyces cerevisiae strains to various antineoplastic agents.
  • * To determine the impact of treatment duration and drug concentration on yeast cell survival.

Main Methods:

  • * Determination of Minimum Inhibitory Concentration (MIC), Minimum Cytotoxic Concentration (MCC), and Median Effective Concentration (EC50).
  • * Cell survival assays were performed on the most sensitive yeast strain (ATCC 2366) using varying drug concentrations and treatment durations.
  • * Correlation analysis between survival curve shapes and MIC/MCC values.

Main Results:

  • * Certain yeast strains exhibited sensitivity to 5-fluorouracil, methotrexate, doxorubicin, and cisplatin.
  • * Other agents like m-amsacrine and vinca alkaloids were inactive at tested concentrations.
  • * Methotrexate and cisplatin significantly reduced cell survival after 6-hour exposure, despite initial MIC/MCC tests suggesting ineffectiveness.

Conclusions:

  • * Saccharomyces cerevisiae strains display differential sensitivity to antineoplastic drugs.
  • * Treatment duration is a critical factor influencing drug efficacy, even for agents initially appearing ineffective based on MIC/MCC.
  • * Further investigation into survival curves can refine understanding of drug-chemosensitivity relationships.

Related Concept Videos